These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34607716)

  • 1. Hemophilia B (Factor IX Deficiency).
    Sidonio RF; Malec L
    Hematol Oncol Clin North Am; 2021 Dec; 35(6):1143-1155. PubMed ID: 34607716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The history of hemophilia.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2014 Jul; 40(5):571-6. PubMed ID: 24911674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetics of hemophilia A and B in man. Factor VIII and factor IX deficiency.
    Antonarakis SE
    Adv Hum Genet; 1988; 17():27-59. PubMed ID: 3142226
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive analysis and prediction of long-term durability of factor IX activity following etranacogene dezaparvovec gene therapy in the treatment of hemophilia B.
    Shah J; Kim H; Sivamurthy K; Monahan PE; Fries M
    Curr Med Res Opin; 2023 Feb; 39(2):227-237. PubMed ID: 36285399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current factor IX replacement options for hemophilia B and the challenges ahead.
    Franchini M; Zaffanello M; Focosi D
    Expert Opin Pharmacother; 2023 Apr; 24(6):729-736. PubMed ID: 36963373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of recombinant factor replacement for hemophilia.
    Sankar AD; Weyand AC; Pipe SW
    Transfus Apher Sci; 2019 Oct; 58(5):596-600. PubMed ID: 31421983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EHL-FIX in haemophilia B carriers with FIX deficiency.
    Marlière C; Maindiaux L; Lambert C; Hermans C
    Haemophilia; 2020 Mar; 26(2):e38-e40. PubMed ID: 31840356
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene Therapy for Hemophilia.
    Nathwani AC; Davidoff AM; Tuddenham EGD
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):853-868. PubMed ID: 28895852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene therapy of haemophilia - has the cure come within reach?].
    Kaczmarek R
    Postepy Biochem; 2018 Dec; 64(4):318-322. PubMed ID: 30656916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of gene transfer for hemophilia A and B.
    Thompson AR
    Thromb Haemost; 1991 Jul; 66(1):119-22. PubMed ID: 1926041
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of hemophilia.
    Lozier JN; High KA
    Hematol Pathol; 1990; 4(1):1-26. PubMed ID: 2111315
    [No Abstract]   [Full Text] [Related]  

  • 13. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and improved AAVenues: current status of hemophilia B gene therapy.
    Brimble MA; Reiss UM; Nathwani AC; Davidoff AM
    Expert Opin Biol Ther; 2016; 16(1):79-92. PubMed ID: 26524468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for hemophilia: the clot thickens.
    High KA
    Hum Gene Ther; 2014 Nov; 25(11):915-22. PubMed ID: 25397928
    [No Abstract]   [Full Text] [Related]  

  • 16. Deficiencies in factors IX and VIII: what is now known.
    Kurachi K; Yao SN; Furukawa M; Kurachi S
    Hosp Pract (Off Ed); 1992 Feb; 27(2):41-51. PubMed ID: 1735764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for hemophilia B.
    Mannucci PM; Franchini M
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):407-14. PubMed ID: 25098797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy for Hemophilia.
    Nienhuis AW; Nathwani AC; Davidoff AM
    Mol Ther; 2017 May; 25(5):1163-1167. PubMed ID: 28411016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B.
    Liles D; Landen CN; Monroe DM; Lindley CM; Read MS; Roberts HR; Brinkhous KM
    Thromb Haemost; 1997 May; 77(5):944-8. PubMed ID: 9184407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.